Child & Adolescent Psychiatry

ASAM’s new youth SUD criteria help clinicians deliver developmentally tailored, prevention-first care with coordinated family and community supports.

New ASAM youth criteria redefine SUD care with brain-stage levels, chronic monitoring, detox safety, and family-centered support.

Deep intracranial frequency stimulation 77.5 Hz high-gamma approach was associated with statistically significant reductions in self-injury behaviors and depressive symptoms in female adolescents with nonsuicidal self-injury.

ASAM announces new youth substance use disorder criteria, promoting early intervention, family-focused care, integrated mental health, and updated levels of treatment.

Dutch psychiatric euthanasia cases surge among young adults, sparking debate over irremediability, activism, and suicide contagion risks.

Here's what clinicians must do when patients admit viewing CSEM: more on state reporting rules, confidentiality limits, and why California is different.

Active Minds is pushing for 988 Lifeline information to be shared on student IDs, boosting crisis access and youth-led policy action to curb suicide and reshape campus support.

Congress backs printing 988 on student ID cards, boosting youth crisis access and funding.

An open letter urges lawmakers to regulate AI chatbots, highlighting their dangers to children's emotional development and mental health.

Tiffani Bell-Washington, MD, MPH shares insights on compassionate lifestyle changes for adolescents facing obesity, emphasizing collaboration and individualized care strategies.

Otsuka Pharmaceutical submits a new drug application for centanafadine for treatment of ADHD, showing significant efficacy across all age groups.

Take a look at the long-term effects of stimulant medications on ADHD, specifically tolerance and its implications for treatment efficacy.

FDA expands Deep TMS therapy for adolescents with major depressive disorder, offering a noninvasive treatment option for underserved youth.

Cingulate's CTx-1301 shows promising phase 3 results for ADHD, offering effective once-daily dosing and potential FDA approval by 2026.

Psychiatry explores extraordinary experiences like near-death experiences and out-of-body experiences, distinguishing them from mental illness to enhance patient care and understanding.

Chatbots engage youth with connection but pose serious risks, potentially harming mental health and fostering unhealthy attachments. Awareness and regulation are crucial.

Black youth, particularly boys, face mischaracterization and punishment in schools.

Effective strategies for managing child agitation focus on individualized care, multidisciplinary support, and proactive interventions to ensure safety and calm.

The FDA has updated ADHD stimulant labels, highlighting weight loss risks in children under 6. Stephen Mateka, DO, shares his updated treatment strategies.

The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals.

Learn more about the critical link between early adversity and psychosis, and the need for targeted interventions and preventive measures.

Online dating transforms connections but often leads to loneliness and mental health issues. How can we encourage safer, more meaningful interactions?

The Lancet Commission report on nonfatal self-harm identifies key challenges, causes, and more.

March 17 through March 23 is National Drug and Alcohol Facts Week 2025.